Skip to main content
Premium Trial:

Request an Annual Quote

Bruce Neri, Clyde Shoresas, Peter O Hanley, Ray Cummings, Mark Kay, Bernard Kolodziej, John Linnan

Premium

Prometheus Laboratories said this week that it has appointed Bruce Neri as vice president of diagnostics R&D, and Clyde Shoresas vice president of marketing.

Neri joins Prometheus from Third Wave Technologies, where he was most recently senior vice president of R&D for its Invader technology. Prior to joining Third Wave, he was vice president of DNA probe development at Becton Dickinson. Shores served in various executive roles at companies such as Amgen and Abbott.


AVI BioPharma has appointed Peter O’Hanley as senior vice president of clinical development and regulatory affairs, and Ray Cummings as vice president of business development, the company said this week.

O’Hanley comes to the company from Maxygen, where he was vice president of clinical development. He received his PhD and MD degrees from the Medical University of South Carolina, and obtained his MPH at the University of California, Berkeley.

Cummings comes to AVI from Cummings Consulting, where he was founder and president. Before founding the firm, he was a vice president of business development at Aradigm. Cummings received his MBA from the University of California, Berkeley. He also received an MS from Harvard University in biochemistry and molecular biology, and a BS in biological sciences from Stanford University.


CombiMatrix has named Mark Kay to its scientific advisory board. Kay is professor in the departments of pediatrics and genetics, and the director of the program in human gene therapy at the Stanford University School of Medicine.


Bruker AXS has promoted Bernard Kolodziej to vice president of finance. Kolodziej was originally hired by Bruker AXS in 1997 and has been CFO for the European operations of Bruker AXS since January 1999. Before joining the company, he held several positions in operations and finance with the Siemens’ X-ray business. He has a master’s degree in business administration, finance, and production engineering from the University of Karlsruhe in Germany.


Agencourt Bioscience this week said it has appointed John Linnan as vice president of sales. Linnan will lead Agencourt's worldwide sales force, which has recently expanded with the addition of three US sales representatives and partnerships with two new international distributors.

Linnan comes to Agencourt from Applied Biosystems, where he was the district sales manager for New England. He has a BA in marketing and management from James Madison University.

Filed under

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.